Moreover, analysis of the Cancer Genome Atlas (TCGA) database for RICTOR alteration demonstrated that RICTOR was amplified in around 13% (132/1016) of patients with lung cancers, including 10.3% in lung adenocarcinoma (53/515) and 15.8% (79/501) in squamous cell carcinoma [26]. The gene discussed is RICTOR; the disease is lung cancer.